background preloader

Stem Cells

Facebook Twitter

Bone Marrow Transplant - How it is performed. Having a bone marrow transplant is a complicated five-stage process. The five stages are: physical examination – to assess your general level of health harvesting – the process of obtaining the stem cells to be used in the transplant conditioning – preparing your body for the transplant transplanting the stem cells recovery period – during which you'll be monitored for any complications or side effects The five stages are described in more detail below.

Physical examination You'll have a thorough physical examination before a stem cell transplant. How healthy you are before the transplant will play a big part in your recovery. As part of the examination, you may have some scans to check the condition of internal organs, such as your liver, heart and lungs. Some of the medication used in the conditioning and recovery process can occasionally cause problems with your organs, so it's important to know how well they're functioning beforehand. Harvesting stem cells Autologous transplantation. UK Regenerative Medicine Platform. RENEURON GROUP Share Price ( RENE,RENE.L,LSE:RENE,LON:RENE)

ReNeuron to appoint new CEO 23-04-2014 StockMarketWire ReNeuron Group said in order to manage the increasing breadth of the Companys clinical, operational and commercial activities, the board is to be reconfigured with the appointment of a new CEO. Corporate update RNS Number : 2606F ReNeuron Group plc 23 April 2014 23 April 2014 AIM: RENE Corporate update Guildford, UK, 23 April 2014: ReNeuron Groupplc (the Company) (AIM: RENE.L), the leading UK-based stem cell therapy company, today announces that, in order to manage the increasing breadth of the Companys clinical, operational and commercial activities, the Board of the Company is to be reconfigured with the appointment of a new Chief ...

Signs Lease to New Facility in Wales ReNeuron gets approvals for two new clinical trials 27-03-2014 StockMarketWire ReNeuron Group, a UK-based stem cell therapy company, has received final UK regulatory and ethical approvals to commence two new clinical trials. UK Clinical Trial Approvals. Cell potency. Totipotency[edit] It is possible for a fully differentiated cell to return to a state of totipotency.[4] This conversion to totipotency is complex, not fully understood and the subject of recent research.

Research in 2011 has shown that cells may differentiate not into a fully totipotent cell, but instead into a "complex cellular variation" of totipotency.[5] The human development model is one which can be used to describe how totipotent cells arise.[6] Human development begins when a sperm fertilizes an egg and the resulting fertilized egg creates a single totipotent cell, a zygote.[7] In the first hours after fertilization, this zygote divides into identical totipotent cells, which can later develop into any of the three germ layers of a human (endoderm, mesoderm, or ectoderm), into cells of the cytotrophoblast layer or syncytiotrophoblast layer of the placenta.

Pluripotency[edit] A: Human embryonic stem cells (cell colonies that are not yet differentiated). Induced pluripotency[edit] University news. Issued: Mon, 27 May 2013 08:00:00 BST Encouraging interim data from the world’s first clinical trial examining the safety of neural stem cell treatment in stroke patients has been reported by researchers ahead of an application for Phase II trials. Updated interim data from the PISCES trial, which has seen the brains of ischaemic stroke patients injected with neural stem cells to test the safety and tolerability of the treatment, was presented to the 22nd European Stroke Conference in London on Tuesday 28 May.

Professor Keith Muir of the University of Glasgow, who is heading the trial of ReNeuron Group plc’s ReN001 stem cell therapy at the Southern General Hospital, Glasgow reported that data from the first nine patients treated has shown no cell-related or immunological adverse affects. A further two patients have been treated since the data were collated and the trial is now drawing to a close, with full results due to be published next year. Notes to Editors About stroke About ReNeuron. University news. Lab-grown kidneys transplanted into rats. Scientists at Massachusetts General Hospital in Boston have fitted rats with kidneys that were grown in a lab from stripped-down kidney scaffolds. When transplanted, these 'bioengineered' organs starting filtering the rodents’ blood and making urine. The team, led by organ-regeneration specialist Harald Ott, started with the kidneys of recently deceased rats and used detergent to strip away the cells, leaving behind the underlying scaffold of connective tissues such as the structural components of blood vessels.

They then regenerated the organ by seeding this scaffold with two cell types: human umbilical-vein cells to line the blood vessels, and kidney cells from newborn rats to produce the other tissues that make up the organ. The work is described today in Nature Medicine1. Ott and his colleagues developed this method in 2008, and he has since used it to grow hearts2 and lungs. Ott Lab, Center for Regenerative Medicine, Massachusetts General Hospital. Pluripotency: Toward a gold standard for human ES and iPS cells - Smith - 2009 - Journal of Cellular Physiology. Www.marcottelab.org/users/CH391L/Handouts/NeuralCellsFromEScells.pdf. Redirection page. Www.sfu.ca/biophysics/frontiers/2008/Jaenisch_Science.pdf.